Breaking News Instant updates and real-time market news.

EL

Estee Lauder

$132.32

-0.33 (-0.25%)

07:14
08/14/18
08/14
07:14
08/14/18
07:14

Estee Lauder price target lowered to $148 from $170 at Oppenheimer

Oppenheimer analyst Rupesh Parikh lowered his price target for Estee Lauder to $148 from $170 ahead of quarterly results. The analyst continues to look "very favorably" upon the company's long-term prospects, but expects a bumpier ride from here given prospects for slowing top and bottom-line growth and increased geopolitical uncertainty. Given the potential for less earnings upside and increased uncertainty near-term, Parikh is removing Estee Lauder as a top pick. The analyst has an Outperform rating on the shares.

  • 20

    Aug

EL Estee Lauder
$132.32

-0.33 (-0.25%)

06/28/18
JEFF
06/28/18
NO CHANGE
Target $145
JEFF
Hold
Estee Lauder fundamentals could lag expectations, says Jefferies
Jefferies analyst Stephanie Wissink sees elevated near-term risk that Estee Lauder's fundamentals could lag expectations for double-digit growth. The analyst sees "signs of moderation in core drivers" and no clear acquisition of size to backfill. Further, the stock is already trading near peak multiples, Wissink tells investors in a research note. She sees downside risk to $125 per share and upside to $150. The analyst keeps a Hold rating on Estee Lauder with a $145 price target.
07/19/18
UBSW
07/19/18
INITIATION
Target $144
UBSW
Neutral
Estee Lauder initiated with a Neutral at UBS
UBS analyst Steven Strycula started Estee Lauder with a Neutral rating and $144 price target. The analyst believes the shares are "priced for success" at current valuation levels.
07/26/18
OPCO
07/26/18
DOWNGRADE
OPCO
Perform
Oppenheimer downgrades e.l.f. Beauty to Perform on estimate risk
Oppenheimer analyst Rupesh Parikh downgraded e.l.f. Beauty (ELF) to Perform from Outperform saying the bull case is more uncertain from here. The analyst does not have a price target for the shares. Recent developments, including "still challenging trends" in the mass category and increased tariff uncertainty, bring greater risk to consensus forecasts, Parikh tells investors in a research note. He is harder-pressed to see the case for share outperformance. Ulta Beauty (ULTA) and Estee Lauder (EL) remain Parikh's top picks in beauty.
07/26/18
07/26/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. PIPER CUTS 3D SYSTEMS TO UNDERWEIGHT: Piper Jaffray analyst Troy Jensen downgraded 3D Systems (DDD) to Underweight from Neutral with a $10 price target. He believes competition for the company's main product lines is intensifying. The analyst also thinks 3D will need to increase spending on direct sales, customer support and consulting, meaning "meaningful profitability" will likely be more challenged than revenue growth throughout 2018. He views the stock as overvalued. While Jensen continues to believe the overall 3D printing industry is "growing rapidly," he remains cautious on shares of 3D Systems and Stratasys (SSYS). He reiterated a Neutral rating on the latter. OPCO CUTS E.L.F. TO PERFORM: Oppenheimer analyst Rupesh Parikh downgraded e.l.f. Beauty (ELF) to Perform from Outperform saying the bull case is more uncertain from here. The analyst does not have a price target for the shares. Recent developments, including "still challenging trends" in the mass category and increased tariff uncertainty, bring greater risk to consensus forecasts, Parikh tells investors in a research note. He is harder-pressed to see the case for share outperformance. Ulta Beauty (ULTA) and Estee Lauder (EL) remain Parikh's top picks in beauty. FACEBOOK GETS MULTIPLE DOWNGRADES AFTER Q2 EARNINGS: Nomura Instinet analyst Mark Kelley downgraded Facebook (FB) to Neutral from Buy after the company delivered "underwhelming" Q2 results and guided for revenue growth deceleration through the end of the year. The revenue guidance paired with the expectation for mid-30% operating margins in the medium term or possibly longer means consensus numbers will be cut "drastically," he said. He lowered his price target on Facebook shares to $183 from $228. Facebook was also downgraded to Neutral from Buy by UBS analyst Eric Sheridan, who also lowered his price target for the shares to $180 from $212, and to Outperform from Strong Buy at Raymond James. Facebook shares are down over 19% in late morning trading. PIPER SAYS BIOGEN SELLOFF A BUYING OPPORTUNITY: Biogen (BIIB) shares "will recover and continue to work" into aducanumab's full Phase 3 data in 2020, Piper Jaffray analyst Christopher Raymond told investors. With the stock having run up into these data, the analyst said he understood the "sell-the-news" phenomenon. He believes, however, that the fundamental concerns he's heard from investors "don't seem to hold water." The analyst said to buy Biogen shares on the selloff. He kept an Overweight rating on the name with a $400 price target.

TODAY'S FREE FLY STORIES

10:21
12/13/18
12/13
10:21
12/13/18
10:21
Conference/Events
JPMorgan Internet analyst to hold an analyst/industry conference call »

Internet Analyst Anmuth…

10:19
12/13/18
12/13
10:19
12/13/18
10:19
Conference/Events
JPMorgan household/personal care analysts hold analyst/industry conference call »

Household & Personal…

SMTC

Semtech

$48.38

0.14 (0.29%)

10:17
12/13/18
12/13
10:17
12/13/18
10:17
Conference/Events
Semtech management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/13/18
12/13
10:17
12/13/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$7.38

0.66 (9.82%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
On The Fly
General Electric jumps as long-time bear ups rating after two and a half years »

Shares of General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIA

Saia

$55.48

0.175 (0.32%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
Conference/Events
Saia management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 20

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGI

Alamos Gold

$3.22

-0.19 (-5.57%)

10:15
12/13/18
12/13
10:15
12/13/18
10:15
Downgrade
Alamos Gold rating change  »

Alamos Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/13/18
12/13
10:15
12/13/18
10:15
General news
Breaking General news story  »

Week of 12/7 EIA Natural…

MAC

Macerich

$49.36

2.23 (4.73%)

, SPG

Simon Property

$184.56

2.05 (1.12%)

10:14
12/13/18
12/13
10:14
12/13/18
10:14
Hot Stocks
Macerich up after Dealreporter speculates on renewed Simon deal interest »

Dealreporter noted that…

MAC

Macerich

$49.36

2.23 (4.73%)

SPG

Simon Property

$184.56

2.05 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.49

-0.04 (-0.16%)

10:10
12/13/18
12/13
10:10
12/13/18
10:10
Options
One-day upside call spread seller in Bank of America »

One-day upside call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

MGLN

Magellan Health

$60.63

2 (3.41%)

10:07
12/13/18
12/13
10:07
12/13/18
10:07
Periodicals
Starboard to push Magellan to improve or sell itself, Bloomberg reports »

Jeff Smith's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:05
12/13/18
12/13
10:05
12/13/18
10:05
General news
Treasury Option Action: put positioning in the belly »

Treasury Option Action:…

10:05
12/13/18
12/13
10:05
12/13/18
10:05
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

ROKU

Roku

$35.30

0.1301 (0.37%)

10:05
12/13/18
12/13
10:05
12/13/18
10:05
Conference/Events
Roku management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

  • 18

    Dec

  • 19

    Dec

CTIC

CTI BioPharma

$1.49

(0.00%)

10:04
12/13/18
12/13
10:04
12/13/18
10:04
Hot Stocks
CTI BioPharma to cut approx. 50% of total workforce in restructuring »

CTI BioPharma announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,075.83

12.27 (1.15%)

, GOOGL

Alphabet Class A

$1,085.00

11.34 (1.06%)

10:04
12/13/18
12/13
10:04
12/13/18
10:04
Periodicals
Google employees instructed to treat TVCs differently, The Guardian reports »

Google employees are…

GOOG

Alphabet

$1,075.83

12.27 (1.15%)

GOOGL

Alphabet Class A

$1,085.00

11.34 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

TSLA

Tesla

$367.70

0.94 (0.26%)

10:04
12/13/18
12/13
10:04
12/13/18
10:04
On The Fly
Analyst sees narrative around Tesla changing as Wired reports on 'rage firings' »

Shares of Tesla (TSLA)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MGLN

Magellan Health

$61.38

2.75 (4.69%)

10:03
12/13/18
12/13
10:03
12/13/18
10:03
Hot Stocks
Magellan rallies after activist Starboard discloses nearly 10% stake »

Jeff Smith's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$20.67

-0.57 (-2.68%)

10:01
12/13/18
12/13
10:01
12/13/18
10:01
Upgrade
TechnipFMC rating change  »

BMO Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PYPL

PayPal

$88.01

1.51 (1.75%)

10:01
12/13/18
12/13
10:01
12/13/18
10:01
Conference/Events
PayPal management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

OXM

Oxford Industries

$67.67

-7.21 (-9.63%)

10:00
12/13/18
12/13
10:00
12/13/18
10:00
Hot Stocks
Oxford Industries falls -9.0% »

Oxford Industries is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$58.45

-6.2 (-9.59%)

10:00
12/13/18
12/13
10:00
12/13/18
10:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN falls -9.8% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$14.56

-5.6 (-27.78%)

10:00
12/13/18
12/13
10:00
12/13/18
10:00
Hot Stocks
Tailored Brands falls -27.5% »

Tailored Brands is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$5.99

0.73 (13.88%)

10:00
12/13/18
12/13
10:00
12/13/18
10:00
Hot Stocks
Qudian rises 13.9% »

Qudian is up 13.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.